We are evaluating the safety and potential effectiveness of OATD-02 in patients with advanced or metastatic solid tumors who have completed an earlier study. This research aims to understand how well this treatment works in this specific group.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced solid tumors refer to cancers that have progressed to an advanced stage, including colorectal cancer, ovarian cancer, pancreatic cancer, and renal cell carcinoma. These cancers can spread to other parts of the body, making treatment more complex.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.